Loading…
Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases
We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the...
Saved in:
Published in: | European journal of obstetrics & gynecology and reproductive biology 2001-12, Vol.100 (1), p.108-111 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 111 |
container_issue | 1 |
container_start_page | 108 |
container_title | European journal of obstetrics & gynecology and reproductive biology |
container_volume | 100 |
creator | Winer, Norbert David, Albert Leconte, Philippe Aubron, Francoise Rogez, Jean-Michel Rival, Jean-Marie Pinaud, Michel Roze, Jean-Christophe Boog, Georges |
description | We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle.
Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24
h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest.
We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread. |
doi_str_mv | 10.1016/S0301-2115(01)00442-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72313512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211501004420</els_id><sourcerecordid>72313512</sourcerecordid><originalsourceid>FETCH-LOGICAL-e293t-5c4dfc580cdf40571e0129ee4054e3fb0e8b586c3306a5373150ffddc2c99edb3</originalsourceid><addsrcrecordid>eNpFkV9rFTEQxUNR2tvWj6DkRWkf1s4km_3TFymlVaEgVH0OucmkRHaTNdkV-u27t73qvJxh-HFgzmHsLcJHBGwuvoMErASiOgM8B6hrUcEB22DXiqptVP2Kbf4hR-y4lF-wjpT9ITtCbEXXtLhh91djDMlSnKmEwk103OwuIfqlhBS5W3KID3zK9BBNtI-X_J6mlGeePPdpydymcRqCNTM5bk2hcspeezMUerPXE_bz9ubH9Zfq7tvnr9dXdxWJXs6VsrXzVnVgna9BtUiAoida95qk3wJ1W9U1VkpojJKtRAXeO2eF7XtyW3nCPrz4Tjn9XqjMegzF0jCYSGkpuhUSpUKxgu_24LIdyekph9HkR_03hRV4vwdMsWbweX00lP-clB3UsDP69MLR-tafQFkXGyhaciGTnbVLQSPoXT_6uR-9C1-v-tyPBvkE0kOBPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72313512</pqid></control><display><type>article</type><title>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</title><source>Elsevier</source><creator>Winer, Norbert ; David, Albert ; Leconte, Philippe ; Aubron, Francoise ; Rogez, Jean-Michel ; Rival, Jean-Marie ; Pinaud, Michel ; Roze, Jean-Christophe ; Boog, Georges</creator><creatorcontrib>Winer, Norbert ; David, Albert ; Leconte, Philippe ; Aubron, Francoise ; Rogez, Jean-Michel ; Rival, Jean-Marie ; Pinaud, Michel ; Roze, Jean-Christophe ; Boog, Georges</creatorcontrib><description>We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle.
Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24
h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest.
We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/S0301-2115(01)00442-0</identifier><identifier>PMID: 11728671</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Amniocentesis ; Amniocentesis - adverse effects ; Amniotic Fluid ; Anti-Bacterial Agents - therapeutic use ; Biological and medical sciences ; Chorioamnionitis - etiology ; Coloring Agents - administration & dosage ; Diseases of mother, fetus and pregnancy ; Dye injection ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - etiology ; Evans Blue - administration & dosage ; Female ; Fetal Diseases - etiology ; Fetal Membranes, Premature Rupture - diagnosis ; Foetal complications ; Gynecology. Andrology. Obstetrics ; Humans ; Karyotyping ; Maternal Age ; Maternal complications ; Medical sciences ; Muscular Atrophy - etiology ; Oligohydramnios - diagnosis ; Pregnancy ; Pregnancy, High-Risk ; Pregnancy. Fetus. Placenta ; Shock, Septic - etiology ; Ultrasonography</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 2001-12, Vol.100 (1), p.108-111</ispartof><rights>2001 Elsevier Science Ireland Ltd</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13380402$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11728671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winer, Norbert</creatorcontrib><creatorcontrib>David, Albert</creatorcontrib><creatorcontrib>Leconte, Philippe</creatorcontrib><creatorcontrib>Aubron, Francoise</creatorcontrib><creatorcontrib>Rogez, Jean-Michel</creatorcontrib><creatorcontrib>Rival, Jean-Marie</creatorcontrib><creatorcontrib>Pinaud, Michel</creatorcontrib><creatorcontrib>Roze, Jean-Christophe</creatorcontrib><creatorcontrib>Boog, Georges</creatorcontrib><title>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle.
Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24
h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest.
We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.</description><subject>Adult</subject><subject>Amniocentesis</subject><subject>Amniocentesis - adverse effects</subject><subject>Amniotic Fluid</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chorioamnionitis - etiology</subject><subject>Coloring Agents - administration & dosage</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Dye injection</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - etiology</subject><subject>Evans Blue - administration & dosage</subject><subject>Female</subject><subject>Fetal Diseases - etiology</subject><subject>Fetal Membranes, Premature Rupture - diagnosis</subject><subject>Foetal complications</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Karyotyping</subject><subject>Maternal Age</subject><subject>Maternal complications</subject><subject>Medical sciences</subject><subject>Muscular Atrophy - etiology</subject><subject>Oligohydramnios - diagnosis</subject><subject>Pregnancy</subject><subject>Pregnancy, High-Risk</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Shock, Septic - etiology</subject><subject>Ultrasonography</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkV9rFTEQxUNR2tvWj6DkRWkf1s4km_3TFymlVaEgVH0OucmkRHaTNdkV-u27t73qvJxh-HFgzmHsLcJHBGwuvoMErASiOgM8B6hrUcEB22DXiqptVP2Kbf4hR-y4lF-wjpT9ITtCbEXXtLhh91djDMlSnKmEwk103OwuIfqlhBS5W3KID3zK9BBNtI-X_J6mlGeePPdpydymcRqCNTM5bk2hcspeezMUerPXE_bz9ubH9Zfq7tvnr9dXdxWJXs6VsrXzVnVgna9BtUiAoida95qk3wJ1W9U1VkpojJKtRAXeO2eF7XtyW3nCPrz4Tjn9XqjMegzF0jCYSGkpuhUSpUKxgu_24LIdyekph9HkR_03hRV4vwdMsWbweX00lP-clB3UsDP69MLR-tafQFkXGyhaciGTnbVLQSPoXT_6uR-9C1-v-tyPBvkE0kOBPw</recordid><startdate>20011210</startdate><enddate>20011210</enddate><creator>Winer, Norbert</creator><creator>David, Albert</creator><creator>Leconte, Philippe</creator><creator>Aubron, Francoise</creator><creator>Rogez, Jean-Michel</creator><creator>Rival, Jean-Marie</creator><creator>Pinaud, Michel</creator><creator>Roze, Jean-Christophe</creator><creator>Boog, Georges</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20011210</creationdate><title>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</title><author>Winer, Norbert ; David, Albert ; Leconte, Philippe ; Aubron, Francoise ; Rogez, Jean-Michel ; Rival, Jean-Marie ; Pinaud, Michel ; Roze, Jean-Christophe ; Boog, Georges</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e293t-5c4dfc580cdf40571e0129ee4054e3fb0e8b586c3306a5373150ffddc2c99edb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Amniocentesis</topic><topic>Amniocentesis - adverse effects</topic><topic>Amniotic Fluid</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chorioamnionitis - etiology</topic><topic>Coloring Agents - administration & dosage</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Dye injection</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - etiology</topic><topic>Evans Blue - administration & dosage</topic><topic>Female</topic><topic>Fetal Diseases - etiology</topic><topic>Fetal Membranes, Premature Rupture - diagnosis</topic><topic>Foetal complications</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Karyotyping</topic><topic>Maternal Age</topic><topic>Maternal complications</topic><topic>Medical sciences</topic><topic>Muscular Atrophy - etiology</topic><topic>Oligohydramnios - diagnosis</topic><topic>Pregnancy</topic><topic>Pregnancy, High-Risk</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Shock, Septic - etiology</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winer, Norbert</creatorcontrib><creatorcontrib>David, Albert</creatorcontrib><creatorcontrib>Leconte, Philippe</creatorcontrib><creatorcontrib>Aubron, Francoise</creatorcontrib><creatorcontrib>Rogez, Jean-Michel</creatorcontrib><creatorcontrib>Rival, Jean-Marie</creatorcontrib><creatorcontrib>Pinaud, Michel</creatorcontrib><creatorcontrib>Roze, Jean-Christophe</creatorcontrib><creatorcontrib>Boog, Georges</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winer, Norbert</au><au>David, Albert</au><au>Leconte, Philippe</au><au>Aubron, Francoise</au><au>Rogez, Jean-Michel</au><au>Rival, Jean-Marie</au><au>Pinaud, Michel</au><au>Roze, Jean-Christophe</au><au>Boog, Georges</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2001-12-10</date><risdate>2001</risdate><volume>100</volume><issue>1</issue><spage>108</spage><epage>111</epage><pages>108-111</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle.
Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24
h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest.
We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>11728671</pmid><doi>10.1016/S0301-2115(01)00442-0</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-2115 |
ispartof | European journal of obstetrics & gynecology and reproductive biology, 2001-12, Vol.100 (1), p.108-111 |
issn | 0301-2115 1872-7654 |
language | eng |
recordid | cdi_proquest_miscellaneous_72313512 |
source | Elsevier |
subjects | Adult Amniocentesis Amniocentesis - adverse effects Amniotic Fluid Anti-Bacterial Agents - therapeutic use Biological and medical sciences Chorioamnionitis - etiology Coloring Agents - administration & dosage Diseases of mother, fetus and pregnancy Dye injection Escherichia coli Infections - drug therapy Escherichia coli Infections - etiology Evans Blue - administration & dosage Female Fetal Diseases - etiology Fetal Membranes, Premature Rupture - diagnosis Foetal complications Gynecology. Andrology. Obstetrics Humans Karyotyping Maternal Age Maternal complications Medical sciences Muscular Atrophy - etiology Oligohydramnios - diagnosis Pregnancy Pregnancy, High-Risk Pregnancy. Fetus. Placenta Shock, Septic - etiology Ultrasonography |
title | Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A54%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amniocentesis%20and%20amnioinfusion%20during%20pregnancy:%20Report%20of%20four%20complicated%20cases&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Winer,%20Norbert&rft.date=2001-12-10&rft.volume=100&rft.issue=1&rft.spage=108&rft.epage=111&rft.pages=108-111&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/S0301-2115(01)00442-0&rft_dat=%3Cproquest_pubme%3E72313512%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e293t-5c4dfc580cdf40571e0129ee4054e3fb0e8b586c3306a5373150ffddc2c99edb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72313512&rft_id=info:pmid/11728671&rfr_iscdi=true |